| Term 
 | Definition 
 
        |     - neurotransmitter in periphery which mediates the effects of sympathetatic  stimulation; - not as potent as Epi; reduces renal and hepatic blood flow |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - hypotension - local vasoconstriction - nasal decongestion -paroxymal atrial tachycardia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   -alpha agonist; reduces renal/hepatic/muscle blood flow- vessels have a lot of alpha receptors in arterioles and NE produces vasoconstriction (reduce the flow of blood through these tissues).  Increases MABP; Reflex bradycardia    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - in the nose there are blood vessels that are subject to vasodilation. When giving a drug that causes vasodilation, you'll get nasal stuffiness. Histamine acts on H1 receptors and produces vasodilation.  An alpha agonist activity will cause vasoconstriction (reduction in the blockage of the nasal mucosal blood vessels). Nasal preparations contain sympathomimetics |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |      - an alpha agonist will combat paroxysmal atrial tachycardia b/c it increases PS stimulation to the heart by causing vasoconstriction; - it has ability to produce reflex bradycardia    
   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - tissue necrosis (slough) due to alpha stimulation (infuse centrally, high on limb) - hyperthyroidism - sensitization of myocardium - contraction of gravid uterus, NOT to use in PG |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     NE is a very potent vasoconstrictor so it  can produce tissue necrosis, when it’s administered or applied to an end organ   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       non-selective beta agonist   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - vascular and nonvascular smooth muscle beta-2 stimulation; - metabolic: hyperglycemia, FFA release; - cardiac stimulation; - bronchoconstriction |  | 
        |  | 
        
        | Term 
 
        |       Dopamine low dose effects |  | Definition 
 
        |   Dopamine agonist effects: - increases renal blood flow (interacts with  dopamine receptors in renal vasculature) - increases glomerular filtration; - increases sodium excretion |  | 
        |  | 
        
        | Term 
 
        |       Dopamine moderate dose effects |  | Definition 
 
        | Dopamine agonist plus beta-1 plus IAS action: - increased cardiac output - increased systolic BP - increased coronary blood flow - no change in tissue peripheral resistance or diastolic BP |  | 
        |  | 
        
        | Term 
 
        |       Dopamine high dose effects |  | Definition 
 
        | Dopamine + beta-1 + indirect (can promote the release of NE) + alpha: - increased PR, increase in HR; the heart is pumping against the increase in PR - renal vasoconstriction, as you see alpha  effects in SC;    - indirect action, promoting the release  of NE from adrenergic nerves   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - shock by continuous infusion, superior to  NE b/c NE produces vasoconstriction, it’s  going to produce decrease in heart rate. - increases blood flow to kidneys &  enhances glomerular filtration      |  | 
        |  | 
        
        | Term 
 
        |       Dopamine- adverse effects |  | Definition 
 
        |     Overdose- similar to those due to  sympathetic stimulation  -nausea, hypertension, arrhythmia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |  - selective beta 1 agonist. It is a cardiac stimulant, synthetic catecholamine, Isoproterenolol derivative.  - produces cardiac beta 1 effects, slight alpha and beta 2 activity - made up of 2 isomers w/ either beta 2 or alpha agonism.  As you increase the dose, you lose the potential to produce  a + iontropic effect w/o producing a chronotropic effect. So at at high doses it resembles ISO .    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 - improved over other catecholamines; less tachycardia,  increase in systolic BP, less effect on oxygen demand,  no decrease in cardiac efficiency. It increases Systolic  BP b/c it increases CO, but less tachycardia. It will NOT cause a decrease in cardiac efficiency  b/c this is due to beta 2 agonists activity.  |  | 
        |  | 
        
        | Term 
 
        |     Comparison at equipotent beta-1 doses   |  | Definition 
 
        | Isoproterenol has NO alpha-1 effects but has a lot of beta-2 agonist activity (+5) NE has a lot of alpha-1 effects (+5) but no beta-2 effects Dobutamine has the same low alpha-1 and beta-2 effects (+1) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |         -some type of shock w/ oliguria |  | 
        |  | 
        
        | Term 
 
        |       Dobutamine adverse effects |  | Definition 
 
        |   - cathecolamine adverse effects; miocardial effects with halogenated hydrocarbons, cardiac arrhythmias, tachycardia (approx. 10%- like ISO) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
   - given IV causes a reflex bradycardia  b/c ofit’s alpha agonist activity. No beta 1 agonist activity is observed  when given IV |  | 
        |  | 
        
        | Term 
 
        |     NE, EPI and ISO  In vitro D/R plots   |  | Definition 
 
        |   Arterial smooth muscle EPI> NE >>>>> ISO Bronchial smooth muscle ISO> EPI >>>>>> NE Cardiac Inotropism ISO > EPI = NE |  | 
        |  | 
        
        | Term 
 
        |     EPI, NE and ISO D/R plots  w/ & w/o Antagonist |  | Definition 
 
        | Arterial smooth muscle NE=NE + Propanolol >>>>NE + Phentolamine Bronchial smooth muscle ISO= ISO +Phentolamine>>>>ISO + Propanolol Cardiac Inotropism NE=NE+ Phentolamine>>>NE+Propanolol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
  In arterial smooth muscle Epi is much more  potent than NE and NE is way more potent  than ISO, because ISO has no alpha agonist  activity. EPI is the most potent of those catecholamines so its ED50 would be much  smaller than that of NE. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       - the most potent beta agonist; -not taken up into adrenergic nerves  (reuptake is not important) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - refers to force of attraction; + iontropism increases the force  of attraction and - iontropism decreases the force of attraction.  So administration of a beta 1 agonist, normally you don’t have  any reflexes acting, drop it right on the heart, you'll have  a + ionitropic effect. Administer a muscarinic agonist drop  it right on the heart will cause a - iontropic effect, b/c  it’s going to reduce the contractile response   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
 + speeds up, - chronotropism it slows down. A drug which has beta 1 agonist activity put it right on the heart it  speeds up the heart, it’s + chronotopism. A drug  put on the heart that slows it down, is - chronotropism. Administration of an adrenergic neuron  blocker in vivo would exibit - chronotropism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
      -given IV will cause reflex bradycardia and hypertension   |  | 
        |  | 
        
        | Term 
 
        |       Adrenergic neuron blocker |  | Definition 
 
        |       - causes a reduction in sympathetic stimulation   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     - produce an increase in heart rate  and contraction  |  | 
        |  | 
        
        | Term 
 
        |   NE NE + propanolol  NE + phentolamine in arterial smooth muscle |  | Definition 
 
        | NE gives the same D/R plot as NE + propanolol (beta blocker),  b/c NE doesn’t bind to beta receptors in the arterioles, to  give you contraction of the arterial smooth muscle. NE + phentolamine (alpha receptor antagonist) will give a big  shift in the dose response curve to the right. So the EC50 will be increased a lot by phentolamine but not by propanolol.  NE works on alpha receptors in the arterial smooth muscle.   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       alpha receptor antagonist |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        |   ISO ISO + Phentolamine ISO + Propanolol on bronchial smooth muscle |  | Definition 
 
        | 
 On bronchial smooth muscle you have beta  2 receptors, and ISO will produce relaxation  of bronchial smooth muscle. ISO plus  phentolamine will not give you a shift  in D/R plot. ISO plus propanolol will give  a big shift in D/R plot to the right. |  | 
        |  | 
        
        | Term 
 
        |   NE NE + Phentolamine NE + Propanolol Cardiac Inotropism |  | Definition 
 
        |  NE plus phentolamine gives no shift in D/R  plot but NE plus propanol gives you a rightward shift in D/R plot. Cardiac inotropism is  mediated via an increase in beta 1 receptor stimulation. Propanolol results in a rightward shift in D/R plot b/c it is blocking the receptor  that NE needs to interact to produce an  incease in heart rate |  | 
        |  |